Lars Rebien Soerensen
Last quote by Lars Rebien Soerensen
The problem is that in the reimbursement market we are now facing it is unlikely that such a tablet could be made available at a price that would be acceptable to the payers.
Nov 16 2016
The latest quote from Lars Rebien Soerensen is: “The problem is that in the reimbursement market we are now facing it is unlikely that such a tablet could be made available at a price that would be acceptable to the payers.”. It comes from the How drug price pressure helped sink Novo's insulin pill article. You’ll find on this page 4 articles with Lars Rebien Soerensen quoted on topics such as U.S. and balance. Lars Rebien Soerensen has been quoted 9 times in 4 articles.
Quotes by Lars Rebien Soerensen
Nov 16 2016
We have amended our research strategy by discontinuing a number of projects that we assess are difficult to commercialize in an environment where there's focus on healthcare costs and payer pressure on us.
Oct 28 2016
We have no intentions of leaving the U.S. market, whatever it costs.
Sep 29 2016
We have concluded that it is needed in order for us to have a sustainable balance between income and costs.
Sep 01 2016
This is an emotional moment for me after having worked 34 years in this company.
This webpage has been created by a robot: errors and absent quotes cannot be totally avoided